Page last updated: 2024-12-05

2,3-dimethylindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2,3-Dimethylindole is a heterocyclic compound with potential applications in various fields. It has been synthesized through various methods, including the Fischer indole synthesis and the reaction of 2-methyl-3-chloropyridine with lithium aluminum hydride. Studies have shown that 2,3-dimethylindole exhibits diverse biological activities. For instance, it has been reported to possess antimicrobial properties against certain bacteria and fungi. It is also being investigated for its potential as an anticancer agent due to its ability to inhibit the growth of cancer cells. 2,3-Dimethylindole's unique structural features make it a promising candidate for the development of novel pharmaceuticals and materials. Its study is driven by its potential to address unmet medical needs and its intriguing chemical properties.
'

Cross-References

ID SourceID
PubMed CID7053
CHEMBL ID3252119
SCHEMBL ID154593
MeSH IDM0096121

Synonyms (39)

Synonym
AKOS000445202
indole, 2,3-dimethyl-
1h-indole, 2,3-dimethyl-
nsc-24936
nsc24936
2,3-dimethylindole
91-55-4
einecs 202-076-2
2,3-dimethyl-1h-indole
nsc 24936
inchi=1/c10h11n/c1-7-8(2)11-10-6-4-3-5-9(7)10/h3-6,11h,1-2h
2,3-dimethylindole, >=97%
D-5350
AC-11743
HMS1648J03
D1579
FT-0641910
unii-tfw7o9hwzk
tfw7o9hwzk ,
FT-0609715
STL377851
CHEMBL3252119
AB00444231-03
2,3-dimethyl indole
SCHEMBL154593
DTXSID6059027
2,3-dimethyl-1h-indole #
Z56867202
mfcd00005617
dimethylindole, 2,3-
F2190-0646
CS-W010999
NCGC00331571-01
F12404
AMY23189
Q27289944
AS-56969
SY048829
EN300-17046
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1133969Toxicity in histamine-induced guinea pig assessed as change in rate of beating in right atrium at 10 ' -5 to 5 x 10' -5 M after 5 mins1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides.
AID1133967Drug excretion in rat urine administered as single dose 1 to 24 hrs prior to ligation1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides.
AID1133965Antiulcer activity in sc dosed albino rat pyloric ligation model assessed as inhibition of gastric secretion administered as single dose 1 to 24 hrs prior to ligation1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides.
AID1133968Anticholinergic activity in mouse assessed as mydriasis at 100 mg/kg, po measured after 1 to 24 hrs post dose1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides.
AID1133966Antiulcer activity in po dosed albino rat pyloric ligation model assessed as inhibition of gastric secretion administered as single dose 1 to 24 hrs prior to ligation1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Experimental antiulcer drugs. 1. Indole-1-alkanamides and pyrrole-1-alkanamides.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.78 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]